NNB®MitoPrime® ——L-麦角硫因（L-Ergothioneine）的抗衰、血管保护和神经保护作用

口服麦角硫因可显著延长小鼠寿命

这一系列论文的共同发现证明了麦角硫因通过细胞线粒体级别的超级抗氧化剂发挥作用。

当NNB旗下品牌EXPlabs在其最新版本的Longevity抗衰胶囊中加入MitoPrime 时，我们感到非常兴奋，因为其添加量达到了单颗胶囊25mg L-麦角硫因（MitoPrime®）。

要知道市面上常见的麦角硫因补充剂只有单颗5mg的剂量（品牌Life Extension： 规格：30粒、5毫克/粒、一瓶总共150毫克EGT、售价219元/瓶）

这是目前为止市面上同类产品中的最高剂量麦角硫因(EGT)，这意味这款产品的效果将非常明显（更高的纯度与剂量也意味着更好的功效表达）。

● MitoPrime经过反复高效液相色谱 (HPLC) 测试证实，纯度接近 100%

注：高效液相色谱 (HPLC) 广泛应用于制药行业，用于分析药物化合物、确保产品质量和确定药物纯度。从原料分析到成品质量控制，它在药物开发的各个阶段都发挥着重要作用。制药科学家依靠 HPLC 对活性药物成分 (API)、杂质和降解产物进行定量分析。

我们认为 MitoPrime 是未来十年甚至二十年皮肤护理和免疫系统支持补充剂的最佳成分，随着研究的深入，越来越多的实验结果证明了这一说法。

麦角硫因在系统中发挥多种作用

全效抗炎

根据一项关于麦角硫因(EGT)和 心血管疾病（CVD） 之间联系的研究：

“麦角硫因是与 HCFP（健康意识食物模式）联系最密切的代谢物，并且与较低的冠心病风险（麦角硫因每 1 个 SD 增量的 HR，HR=0.85，p=0.01）、心血管死亡率（HR= 0.79，p=0.002）和总死亡率（HR=0.86，p=4e-5）。”[29]

本摘录中提到的HCFP代表健康意识食物模式，该研究的作者认为这种饮食方式可以降低人患 CVD 的风险。

他们发现，某些与较低的 CVD 风险密切相关的食物（如水果、浆果、坚果、豆类和酸奶）都具有增加血液麦角硫因(EGT)水平的关键相似之处。[29,30]

在另一项研究中，同一研究小组得出结论：“麦角硫因与 HCFP 的关联性最强，并且与独立于传统危险因素的心脏代谢发病率和死亡率具有最明显的保护性关联。”[29]

换句话说，高麦角硫因含量是这些明显不同的健康食品背后的共同点。听起来像我们日常摄入的维生素。

在身体的所有器官中，大脑可能是最容易受到炎症和氧化应激损害的。[31]

因此，我们认为您会同意健康的大脑老化是延长寿命和高质量生活的关键，麦角硫因在这方面也可以帮助我们。

MitoPrime是可靠的膳食补充剂成分，与人类健康的许多重要方面相关。它几乎与生物生命本身一样古老，并且在含氧和非含氧条件下都能改善细胞功能。

说实话，我们认为这个行业一直在麦角硫因上做表面文章，从未有人去深度挖掘它——当一种成分被低估时，成本和品控问题往往是配方师犹豫使用它的一个重要原因。

希望随着人们越来越认识到 NNB 已发布了近100% 纯度且标准化的麦角硫因异构体，我们将看到麦角硫因得到市场应有的认可度和消费者信赖。

这是目前为止市面上同类产品中的最高剂量，这意味这款产品的效果将非常明显（更高的纯度与剂量也意味着更好的功效表达）。

  

参考文献：

1. Biswas, Subrata Kumar; “Does the Interdependence between Oxidative Stress and Inflammation Explain the Antioxidant Paradox?”; Oxidative medicine and cellular longevity; vol. 2016; 2016; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736408/

2. Halliwell, Barry; “The antioxidant paradox”; The Lancet; 355(9210):1179-80; April 1, 2000; https://www.ncbi.nlm.nih.gov/pubmed/10791396/

3. Halliwell, Barry; “The antioxidant paradox: less paradoxical now?” British journal of clinical pharmacology; vol. 75,3: 637-44; 2013; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575931/

4. Rehman, A, et al; “The effects of iron and vitamin C co-supplementation on oxidative damage to DNA in healthy volunteers”; Biochemical and Biophysical Research Communications; 246(1):293-8; May 8, 1998; https://www.ncbi.nlm.nih.gov/pubmed/9600109

5. Podmore, Ian D, et al; “Vitamin C exhibits pro-oxidant properties”; Nature; 392, page 559; 1998; https://www.nature.com/articles/33308

6. Ramirez-Martinez, Alejandra, et al. “Intake Assessment of L-Ergothioneine in Some European Countries and in the United States.” Human and Ecological Risk Assessment: An International Journal, vol. 22, no. 3, 23 Oct. 2015, pp. 667–677, 10.1080/10807039.2015.1104241; https://www.tandfonline.com/doi/full/10.1080/10807039.2015.1104241

7. Asahi, Takashi et al. “A mushroom-derived amino acid, ergothioneine, is a potential inhibitor of inflammation-related DNA halogenation.” Bioscience, biotechnology, and biochemistry vol. 80,2 (2016): 313-7. doi:10.1080/09168451.2015.1083396; https://academic.oup.com/bbb/article/80/2/313/5939193

8. Stoffels, Christopher, et al; “Ergothioneine stands out from hercynine in the reaction with singlet oxygen: Resistance to glutathione and TRIS in the generation of specific products indicates high reactivity”; Free Radical Biology and Medicine; Volume 113, Pages 385-394; December 2017; https://www.sciencedirect.com/science/article/abs/pii/S0891584917311553

9. Julia Tschirka, Madlen Kreisor, Janina Betz and Dirk Gründemann; “Substrate Selectivity Check of the Ergothioneine Transporter”; Drug Metabolism and Disposition; 46(6):779-785; June 2018; https://dmd.aspetjournals.org/content/46/6/779.long

10. Beelman, Robert B et al. “Is ergothioneine a ‘longevity vitamin’ limited in the American diet?.” Journal of nutritional science vol. 9 e52. 11 Nov. 2020, doi:10.1017/jns.2020.44; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7681161/

11. Ames, Bruce N. “Prolonging healthy aging: Longevity vitamins and proteins.” Proceedings of the National Academy of Sciences of the United States of America vol. 115,43 (2018): 10836-10844. doi:10.1073/pnas.1809045115; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205492/

12. Paul, B D, and S H Snyder. “The Unusual Amino Acid L-Ergothioneine Is a Physiologic Cytoprotectant.” Cell Death & Differentiation, vol. 17, no. 7, 13 Nov. 2009, pp. 1134–1140, doi:10.1038/cdd.2009.163; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2885499/

13. University of Basel; “The vitamin ergothioneine—an antioxidant for oxygen-free areas?”; October 4, 2017; https://phys.org/news/2017-10-vitamin-ergothioneinean-antioxidant-oxygen-free-areas.html

14. Gründemann, Dirk et al. “Discovery of the ergothioneine transporter.” Proceedings of the National Academy of Sciences of the United States of America vol. 102,14 (2005): 5256-61. doi:10.1073/pnas.0408624102; https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/15795384/

15. Cheah, Irwin K, and Barry Halliwell. “Could Ergothioneine Aid in the Treatment of Coronavirus Patients?.” Antioxidants (Basel, Switzerland) vol. 9,7 595. 7 Jul. 2020, doi:10.3390/antiox9070595; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402156/

16. Cheah, Irwin K et al. “Administration of Pure Ergothioneine to Healthy Human Subjects: Uptake, Metabolism, and Effects on Biomarkers of Oxidative Damage and Inflammation.” Antioxidants & redox signaling vol. 26,5 (2017): 193-206. doi:10.1089/ars.2016.6778; https://www.liebertpub.com/doi/10.1089/ars.2016.6778

17. Laurenza, Incoronata et al. “Modulation of palmitic acid-induced cell death by ergothioneine: evidence of an anti-inflammatory action.” BioFactors (Oxford, England) vol. 33,4 (2008): 237-47. doi:10.1002/biof.5520330401; https://iubmb.onlinelibrary.wiley.com/doi/abs/10.1002/biof.5520330401

18. Sakrak, Omer et al. “Ergothioneine modulates proinflammatory cytokines and heat shock protein 70 in mesenteric ischemia and reperfusion injury.” The Journal of surgical research vol. 144,1 (2008): 36-42. doi:10.1016/j.jss.2007.04.020; https://linkinghub.elsevier.com/retrieve/pii/S0022-4804(07)00277-6

19. Repine, John E, and Nancy D Elkins. “Effect of ergothioneine on acute lung injury and inflammation in cytokine insufflated rats.” Preventive medicine vol. 54 Suppl,Suppl (2012): S79-82. doi:10.1016/j.ypmed.2011.12.006; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3355229/

20. Wang, Dawei et al. “Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.” JAMA vol. 323,11 (2020): 1061-1069. doi:10.1001/jama.2020.1585; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308057/

21. Zuo, Yu et al. “Neutrophil extracellular traps in COVID-19.” JCI insight vol. 5,11 e138999. 4 Jun. 2020, doi:10.1172/jci.insight.138999; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308057/

22. Valachová, Katarína et al. “The importance of ergothioneine synthesis in ancient time by organisms living in oxygen free atmosphere.” Medical hypotheses vol. 123 (2019): 72-73. doi:10.1016/j.mehy.2018.12.015; https://linkinghub.elsevier.com/retrieve/pii/S0306-9877(18)31118-6

23. Ruszczycky, Mark W, and Hung-Wen Liu. “Biochemistry: The surprising history of an antioxidant.” Nature vol. 551,7678 (2017): 37-38. doi:10.1038/551037a; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830134/

24. Fuchs, Tobias A et al. “Extracellular DNA traps promote thrombosis.” Proceedings of the National Academy of Sciences of the United States of America vol. 107,36 (2010): 15880-5. doi:10.1073/pnas.1005743107; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936604/

25. Hatano, Taku et al. “Identification of novel biomarkers for Parkinson’s disease by metabolomic technologies.” Journal of neurology, neurosurgery, and psychiatry vol. 87,3 (2016): 295-301. doi:10.1136/jnnp-2014-309676; https://jnnp.bmj.com/content/87/3/295.long

26. Cheah, Irwin K et al. “Ergothioneine levels in an elderly population decrease with age and incidence of cognitive decline; a risk factor for neurodegeneration?.” Biochemical and biophysical research communications vol. 478,1 (2016): 162-167. doi:10.1016/j.bbrc.2016.07.074; https://linkinghub.elsevier.com/retrieve/pii/S0006-291X(16)31196-2

27. Wu, Liu-Yun, et al. “Low Plasma Ergothioneine Predicts Cognitive and Functional Decline in an Elderly Cohort Attending Memory Clinics.” Antioxidants, vol. 11, no. 9, 30 Aug. 2022, p. 1717, doi:10.3390/antiox11091717; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495818/

28. Wu, Liu-Yun, et al. “Low Plasma Ergothioneine Levels Are Associated with Neurodegeneration and Cerebrovascular Disease in Dementia.” Free Radical Biology and Medicine, vol. 177, Dec. 2021, pp. 201–211, doi:10.1016/j.freeradbiomed.2021.10.019; https://pubmed.ncbi.nlm.nih.gov/34673145/

29. Smith, Einar et al. “Ergothioneine is associated with reduced mortality and decreased risk of cardiovascular disease.” Heart (British Cardiac Society) vol. 106,9 (2020): 691-697. doi:10.1136/heartjnl-2019-315485; https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31672783/

30. Ericson, Ulrika et al. “A Health-Conscious Food Pattern Is Associated with Prediabetes and Gut Microbiota in the Malmö Offspring Study.” The Journal of nutrition vol. 150,4 (2020): 861-872. doi:10.1093/jn/nxz293; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138670/

31. Cobley, James Nathan et al. “13 reasons why the brain is susceptible to oxidative stress.” Redox biology vol. 15 (2018): 490-503. doi:10.1016/j.redox.2018.01.008; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881419/

32. Yang, Nae-Cherng et al. “Ergothioneine protects against neuronal injury induced by β-amyloid in mice.” Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association vol. 50,11 (2012): 3902-11. doi:10.1016/j.fct.2012.08.021; https://linkinghub.elsevier.com/retrieve/pii/S0278-6915(12)00585-6

33. Moncaster, Juliet A et al. “Ergothioneine treatment protects neurons against N-methyl-D-aspartate excitotoxicity in an in vivo rat retinal model.” Neuroscience letters vol. 328,1 (2002): 55-9. doi:10.1016/s0304-3940(02)00427-5; https://linkinghub.elsevier.com/retrieve/pii/S0304394002004275

34. ‌Song, Tuzz-Ying et al. “Ergothioneine protects against neuronal injury induced by cisplatin both in vitro and in vivo.” Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association vol. 48,12 (2010): 3492-9. doi:10.1016/j.fct.2010.09.030; https://linkinghub.elsevier.com/retrieve/pii/S0278-6915(10)00606-X

35. Ishimoto, Takahiro et al. “Organic cation transporter-mediated ergothioneine uptake in mouse neural progenitor cells suppresses proliferation and promotes differentiation into neurons.” PloS one vol. 9,2 e89434. 25 Feb. 2014, doi:10.1371/journal.pone.0089434; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3934899/

36. Nakamichi, Noritaka et al. “Oral Administration of the Food-Derived Hydrophilic Antioxidant Ergothioneine Enhances Object Recognition Memory in Mice.” Current molecular pharmacology vol. 14,2 (2021): 220-233. doi:10.2174/1874467213666200212102710; https://www.eurekaselect.com/179259/article

37. Cheah, Irwin K., and Barry Halliwell. “Ergothioneine; Antioxidant Potential, Physiological Function and Role in Disease.” Biochimica et Biophysica Acta (BBA) – Molecular Basis of Disease, vol. 1822, no. 5, 1 May 2012, pp. 784–793, doi:10.1016/j.bbadis.2011.09.017; https://www.sciencedirect.com/science/article/pii/S0925443911002201

38. Markova, Nelli G., et al. “Skin Cells and Tissue Are Capable of Using L-Ergothioneine as an Integral Component of Their Antioxidant Defense System.” Free Radical Biology & Medicine, vol. 46, no. 8, 15 Apr. 2009, pp. 1168–1176, 10.1016/j.freeradbiomed.2009.01.021; https://pubmed.ncbi.nlm.nih.gov/19439218/

39. Bazela, Karolina, et al. “L-Ergothioneine Protects Skin Cells against UV-Induced Damage—a Preliminary Study.” Cosmetics, vol. 1, no. 1, 20 Mar. 2014, pp. 51–60, 10.3390/cosmetics1010051; https://www.mdpi.com/2079-9284/1/1/51

40. Hseu, You-Cheng, et al. “The Antiaging Activity of Ergothioneine in UVA-Irradiated Human Dermal Fibroblasts via the Inhibition of the AP-1 Pathway and the Activation of Nrf2-Mediated Antioxidant Genes.” Oxidative Medicine and Cellular Longevity, vol. 2020, 12 Feb. 2020, pp. 1–13, 10.1155/2020/2576823; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038158/

41. Hseu, You-Cheng, et al. “Dermato-Protective Properties of Ergothioneine through Induction of Nrf2/ARE-Mediated Antioxidant Genes in UVA-Irradiated Human Keratinocytes.” Free Radical Biology and Medicine, vol. 86, Sept. 2015, pp. 102–117, 10.1016/j.freeradbiomed.2015.05.026; https://pubmed.ncbi.nlm.nih.gov/26021820/

42. Schauss, Alexander G., et al. “The Effect of Ergothioneine on Clastogenic Potential and Mutagenic Activity.” International Journal of Toxicology, vol. 30, no. 4, 19 July 2011, pp. 405–409, 10.1177/1091581811405856; https://journals.sagepub.com/doi/full/10.1177/1091581811405856

43. Valachova, Katarina, et al. “Impact of Ergothioneine, Hercynine, and Histidine on Oxidative Degradation of Hyaluronan and Wound Healing.” Polymers, vol. 13, no. 1, 29 Dec. 2020, p. 95, 10.3390/polym13010095; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795610/

44. Cheah, Irwin K, and Barry Halliwell. “Ergothioneine, recent developments.” Redox biology vol. 42 (2021): 101868. doi:10.1016/j.redox.2021.101868; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113028/

45. Marone, Palma Ann et al. “A Safety Evaluation of a Nature-Identical l-Ergothioneine in Sprague Dawley Rats.” International journal of toxicology vol. 35,5 (2016): 568-83. doi:10.1177/1091581816653375; https://journals.sagepub.com/doi/10.1177/1091581816653375

46. Turck, Dominique, et al. “Safety of Synthetic L‐Ergothioneine (Ergoneine®) as a Novel Food pursuant to Regulation (EC) No 258/97.” EFSA Journal, vol. 14, no. 11, Nov. 2016, 10.2903/j.efsa.2016.4629; https://efsa.onlinelibrary.wiley.com/doi/full/10.2903/j.efsa.2016.4629

47. Blue California; “GRAS Notification of Ergothioneine Food Usage Conditions for General Recognition of Safety.” FDA.gov, 2017, http://www.fda.gov/files/food/published/GRAS-Notice-000734–Ergothionine.pdf (archive)

48. Adams, Michael A, Keefe, Dennis M (FDA); “Agency Response Letter Re: GRAS Notice No. GRN 000734: Ergothioneine”; United States Food and Drug Administration; https://www.fda.gov/media/113846/download (archive)